Código QR (código de barras bidimensional)

An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primatesResearch in context

Summary: Background: Angiopoietin-like protein 4 (ANGPTL4) inhibition is a promising approach to manage atherogenic dyslipidaemia and residual atherosclerotic cardiovascular disease (ASCVD) risk. Human ANGPTL4 loss-of-function (LoF) is associated with reduced plasma triglyceride (TG), remnant chole...

Fuld beskrivelse

Na minha lista:
Principais autores: Beryl B. Cummings, Page R. Bouchard, Mark N. Milton, Peter F. Moesta, Vyas Ramanan, John W. Trauger, Eleftheria Maratos-Flier, Andrei Voznesensky, Igor Splawski, Amitabh V. Nimonkar, Keith DiPetrillo, Daniel LaSala, Meihui Pan, Meghan M. Flaherty, Francois Huet, Sukhdeep K. Sahambi, Jijun Dong, Deborah Knee, Regis Cebe, Thomas Huber, Joshua Lehrer-Graiwer, Rebecca A. Juliano, Ethan J. Weiss
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2025-07-01
Serier:EBioMedicine
Fag:
MAR001
ANGPTL4
Triglyceride
Remnant cholesterol
Non-human primates
Safety
Online adgang:http://www.sciencedirect.com/science/article/pii/S2352396425001926
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker